Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-21 Purchase | 2022-03-22 7:28 pm | Design Therapeutics Inc. | DSGN | William Arsani Director | 25,000 | $18.99 | $474,680 | 6,047,629 (Indirect) | View |
| 2022-03-18 Sale | 2022-03-22 7:26 pm | Design Therapeutics Inc. | DSGN | Xu Stella Director | 590,880 | $19.07 | $11,266,197 | 4,139,950 (Indirect) | View |
| 2021-08-31 Purchase | 2021-09-02 5:06 pm | Design Therapeutics Inc. | DSGN | William Arsani Director | 40,000 | $15.45 | $618,000 | 6,022,629 (Indirect) | View |
| 2021-03-30 Purchase | 2021-04-01 6:35 pm | Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer | 3,050 | $20 | $61,000 | 3,050 (Indirect) | View |
| 2021-03-30 Purchase | 2021-04-01 6:23 pm | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 250,000 | $20 | $5,000,000 | 5,626,476 (Direct) | View |
| 2021-03-30 Purchase | 2021-04-01 6:19 pm | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 10,000 | $20 | $200,000 | 4,730,830 (Indirect) | View |
| 2021-03-30 Purchase | 2021-04-01 6:18 pm | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 250,000 | $20 | $5,000,000 | 5,626,476 (Indirect) | View |
| 2021-03-30 Purchase | 2021-04-01 6:17 pm | Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director | 5,000 | $20 | $100,000 | 97,024 (Direct) | View |
| 2021-03-30 Purchase | 2021-04-01 6:16 pm | Design Therapeutics Inc. | DSGN | Shah Pratik Chairman | 25,000 | $20 | $500,000 | 154,923 (Indirect Direct) | View |
| 2021-03-30 Purchase | 2021-04-01 6:14 pm | Design Therapeutics Inc. | DSGN | Thacker Justin VP | 17,500 | $20 | $350,000 | 17,500 (Direct) | View |
| 2021-03-30 Purchase | 2021-04-01 6:12 pm | Design Therapeutics Inc. | DSGN | William Arsani Director | 700,000 | $20 | $14,000,000 | 2,732,501 (Indirect) | View |
| 2021-03-30 Purchase | 2021-04-01 4:15 pm | Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 750,000 | $20 | $15,000,000 | 5,114,844 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-15 Option Award | 2022-06-16 5:17 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Xu Stella Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:16 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:10 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:08 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | William Arsani Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:07 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:06 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:05 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Berger Heather A. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-03-16 Other | 2022-03-18 5:37 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 11,806 | $0 | 23,612 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 7:51 pm | N/A 2032-01-31 | Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 7:50 pm | N/A 2032-01-31 | Design Therapeutics Inc. | DSGN | Shah Pratik Chairman | 475,000 | $0 | 475,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 7:50 pm | N/A 2032-01-31 | Design Therapeutics Inc. | DSGN | Siffert Joao MD CEO | 475,000 | $0 | 475,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 7:49 pm | N/A 2032-01-31 | Design Therapeutics Inc. | DSGN | Burgess Julie CAO | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-10-01 Option Award | 2021-10-04 4:53 pm | N/A 2031-09-30 | Design Therapeutics Inc. | DSGN | Burgess Julie CAO | 135,000 | $0 | 135,000 (Direct) | View |
| 2021-08-13 Ownership | 2021-08-17 7:21 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Giangiulio Dawn Principal Accounting Officer | 0 | $0 | 44,308 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 5:21 pm | N/A 2031-06-14 | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-06-15 Ownership | 2021-06-16 5:20 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 0 | $0 | 1,817,273 (Indirect) | View |
| 2021-06-15 Option Award | 2021-06-16 5:17 pm | N/A 2031-06-14 | Design Therapeutics Inc. | DSGN | Behanna Heather Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:25 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Quan Venture Fund II L.P. 10% Owner | 12,415,784 | $0 | 4,720,830 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:23 pm | N/A N/A | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 14,140,132 | $0 | 5,626,476 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:19 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 12,415,784 | $0 | 4,730,830 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:18 pm | N/A N/A | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 14,140,132 | $0 | 5,626,476 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:16 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Shah Pratik Chairman | 275,948 | $0 | 154,923 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 6:12 pm | N/A N/A | Design Therapeutics Inc. | DSGN | William Arsani Director | 5,345,479 | $0 | 2,732,501 (Indirect) | View |
| 2021-03-30 Conversion | 2021-04-01 4:15 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 8,729,688 | $0 | 5,114,844 (Indirect) | View |
| 2021-03-25(A) Ownership | 2021-03-30 5:44 pm | N/A N/A | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 0 | $0 | 5,376,476 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 6:31 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 5:56 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | William Arsani Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 5:55 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 5:54 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 5:52 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Ownership | 2021-03-25 9:17 pm | N/A N/A | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP 10% Owner | 0 | $0 | 5,376,476 (Direct) | View |
| 2021-03-25 Ownership | 2021-03-25 9:15 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Xu Stella Quan Venture Fund II L.P. Director 10% Owner | 0 | $0 | 4,720,830 (Indirect) | View |